JAMA Psychiatry,
Год журнала:
2024,
Номер
81(3), С. 292 - 292
Опубликована: Янв. 31, 2024
There
is
growing
interest
in
the
role
of
gut
microbiome
composition
schizophrenia.
However,
lifestyle
factors
are
often
neglected,
and
few
studies
have
investigated
treatment-resistant
Pharmacological Research,
Год журнала:
2021,
Номер
172, С. 105840 - 105840
Опубликована: Авг. 24, 2021
Emerging
evidence
indicates
that
the
gut
microbiota
play
a
crucial
role
in
bidirectional
communication
between
and
brain
suggesting
microbes
may
shape
neural
development,
modulate
neurotransmission
affect
behavior,
thereby
contribute
to
pathogenesis
and/or
progression
of
many
neurodevelopmental,
neuropsychiatric,
neurological
conditions.
This
review
summarizes
recent
data
on
microbiota-gut-brain
axis
pathophysiology
neuropsychiatric
disorders
including
depression,
anxiety,
schizophrenia,
autism
spectrum
disorders,
Parkinson's
disease,
migraine,
epilepsy.
Also,
involvement
co-existing
with
conditions
is
highlighted.
We
discuss
from
both
vivo
preclinical
experiments
clinical
reports
including:
(1)
studies
germ-free
animals,
(2)
exploring
composition
animal
models
diseases
or
humans,
(3)
evaluating
effects
probiotic,
prebiotic
antibiotic
treatment
as
well
(4)
fecal
transplantation.
JAMA Psychiatry,
Год журнала:
2021,
Номер
78(12), С. 1343 - 1343
Опубликована: Сен. 15, 2021
Evidence
of
gut
microbiota
perturbations
has
accumulated
for
multiple
psychiatric
disorders,
with
signatures
proposed
as
potential
biomarkers.
However,
no
attempts
have
been
made
to
evaluate
the
specificity
these
across
range
conditions.
Molecular Psychiatry,
Год журнала:
2022,
Номер
27(4), С. 1920 - 1935
Опубликована: Фев. 22, 2022
Abstract
The
emerging
understanding
of
gut
microbiota
as
‘metabolic
machinery’
influencing
many
aspects
physiology
has
gained
substantial
attention
in
the
field
psychiatry.
This
is
largely
due
to
overlapping
pathophysiological
mechanisms
associated
with
both
potential
functionality
and
biological
thought
be
underpinning
mental
disorders.
In
this
systematic
review,
we
synthesised
current
literature
investigating
differences
composition
people
major
psychiatric
disorders,
depressive
disorder
(MDD),
bipolar
(BD)
schizophrenia
(SZ),
compared
‘healthy’
controls.
We
also
explored
across
disorders
an
attempt
elucidate
commonalities
microbial
signatures
these
Following
PRISMA
guidelines,
databases
were
searched
from
inception
through
December
2021.
identified
44
studies
(including
a
total
2510
cases
2407
controls)
that
met
inclusion
criteria,
which
24
investigated
MDD,
seven
BD,
15
SZ.
Our
syntheses
provide
no
strong
evidence
for
difference
number
or
distribution
(α-diversity)
bacteria
those
However,
relatively
consistent
reporting
overall
community
(β-diversity)
without
specific
bacterial
taxa
commonly
including
lower
levels
genera
produce
short-chain
fatty
acids
(e.g.
butyrate),
higher
lactic
acid-producing
bacteria,
glutamate
GABA
metabolism.
observed
heterogeneity
regards
methodologies
reporting.
Further
prospective
experimental
research
using
new
tools
robust
guidelines
hold
promise
improving
our
role
brain
health
development
interventions
based
on
modification
microbiota.
Frontiers in Immunology,
Год журнала:
2020,
Номер
11
Опубликована: Апрель 3, 2020
The
intestinal
tract
is
the
largest
digestive
organ
in
human
body.
It
colonized
by,
and
consistently
exposed
to,
a
myriad
of
microorganisms,
including
bifidobacteria,
lactobacillus,
Escherichia
coli,
enterococcus,
clostridium
perfringens,
pseudomonas.
To
protect
body
from
potential
pathogens,
has
evolved
regional
immune
characteristics.
These
characteristics
are
defined
by
its
unique
structure,
function,
microenvironment,
which
differ
drastically
those
common
central
peripheral
organs.
microenvironment
created
flora
products
significantly
affects
function
region.
In
turn,
specific
diseases
regulate
influence
composition
flora.
A
constant
interplay
occurs
between
system.
Further,
can
be
reconstructed
probiotic
use
or
microbiota
transplantation,
functioning
to
recalibrate
homeostasis,
while
also
contributing
treatment
amelioration
diseases.
this
review,
we
summarize
relationship
occurrence
development
as
an
in-turn
effect
on
immunity.
We
discuss
improved
it
relates
non-specific
proliferation,
differentiation
secretion
cells,
within
region
following
remodeling
means
ameliorate
treat
Finally,
suggest
strategies
for
utilization
Advances in Therapy,
Год журнала:
2020,
Номер
37(4), С. 1328 - 1346
Опубликована: Март 4, 2020
The
human
gut
microbiome
partakes
in
a
bidirectional
communication
pathway
with
the
central
nervous
system
(CNS),
named
microbiota–gut–brain
axis.
axis
is
believed
to
modulate
various
processes
through
vagus
nerve
as
well
production
of
microbial
metabolites
and
immune
mediators
which
trigger
changes
neurotransmission,
neuroinflammation,
behavior.
Little
understood
about
utilization
manipulation
treat
disease.
Though
studies
exploring
role
disease
have
shown
promise,
mechanisms
remain
unclear
evidence-based
treatments
for
most
illnesses
not
yet
been
developed.
animal
reviewed
here
offer
an
excellent
array
basic
science
research
that
continues
clarify
by
may
affect
mental
health.
More
evidence
needed,
particularly
it
relates
translating
this
work
subjects.
presented
paper
largely
demonstrate
encouraging
results
treatment
depression.
Limitations
include
small
sample
sizes
heterogeneous
methodology.
exact
mechanism
microbiota
causes
or
alters
neuropsychiatric
states
fully
understood.
In
review,
we
focus
on
recent
investigating
relationship
between
dysbiosis
pathogenesis
This
article
based
previously
conducted
does
contain
any
participants
animals
performed
authors.
Neuroscience & Biobehavioral Reviews,
Год журнала:
2021,
Номер
125, С. 698 - 761
Опубликована: Март 5, 2021
There
is
increasing
knowledge
regarding
the
role
of
microbiome
in
modulating
brain
and
behaviour.
Indeed,
actions
microbial
metabolites
are
key
for
appropriate
gut-brain
communication
humans.
Among
these
metabolites,
short-chain
fatty
acids,
tryptophan,
bile
acid
metabolites/pathways
show
strong
preclinical
evidence
involvement
various
aspects
function
With
identification
neuroactive
modules,
new
predictive
tools
can
be
applied
to
existing
datasets.
We
identified
278
studies
relating
human
microbiota-gut-brain
axis
which
included
sequencing
data.
This
spanned
across
psychiatric
neurological
disorders
with
a
small
number
also
focused
on
normal
behavioural
development.
consistent
bioinformatics
pipeline,
thirty-five
datasets
were
reanalysed
from
publicly
available
raw
files
remainder
summarised
collated.
studies,
we
uncovered
disease-related
alterations
metabolic
pathways
Alzheimer's
Disease,
schizophrenia,
anxiety
depression.
Amongst
that
could
not
reanalysed,
many
technical
limitations
hindered
discovery
specific
biomarkers
microbes
or
conserved
studies.
Future
warranted
confirm
our
findings.
propose
guidelines
future
analysis
increase
reproducibility
consistency
within
field.
Frontiers in Cell and Developmental Biology,
Год журнала:
2022,
Номер
10
Опубликована: Апрель 14, 2022
The
gut
microbiome
has
a
tremendous
influence
on
human
physiology,
including
the
nervous
system.
During
fetal
development,
initial
colonization
of
coincides
with
development
system
in
timely,
coordinated
manner.
Emerging
studies
suggest
an
active
involvement
and
its
metabolic
by-products
regulating
early
brain
development.
However,
any
disruption
during
this
developmental
process
can
negatively
impact
functionality,
leading
to
range
neurodevelopment
neuropsychiatric
disorders
(NPD).
In
review,
we
summarize
recent
evidence
as
how
association
major
neurodevelopmental
psychiatric
such
autism
spectrum
disorders,
attention-deficit
hyperactivity
disorder,
schizophrenia.
Further,
discuss
alterations
also
play
role
inducing
drug
resistance
affected
individuals.
We
propose
model
that
establishes
direct
link
dysbiosis
exacerbated
inflammatory
state,
functional
deficits
associated
NPD.
Based
existing
research,
framework
whereby
diet
intervention
boost
mental
wellness
subjects
call
for
further
research
better
understanding
mechanisms
govern
gut-brain
axis
may
lead
novel
approaches
study
pathophysiology
treatment
disorders.
Nature Reviews Gastroenterology & Hepatology,
Год журнала:
2024,
Номер
21(4), С. 222 - 247
Опубликована: Фев. 14, 2024
Crosstalk
between
gut
and
brain
has
long
been
appreciated
in
health
disease,
the
microbiota
is
a
key
player
communication
these
two
distant
organs.
Yet,
mechanisms
through
which
influences
development
function
of
gut–brain
axis
remain
largely
unknown.
Barriers
present
are
specialized
cellular
interfaces
that
maintain
strict
homeostasis
different
compartments
across
this
axis.
These
barriers
include
epithelial
barrier,
blood–brain
barrier
blood–cerebrospinal
fluid
barrier.
ideally
positioned
to
receive
communicate
microbial
signals
constituting
gateway
for
gut–microbiota–brain
communication.
In
Review,
we
focus
on
how
modulation
by
can
constitute
an
important
channel
Moreover,
malfunction
upon
alterations
composition
could
form
basis
various
conditions,
including
often
comorbid
neurological
gastrointestinal
disorders.
Thus,
should
unravelling
molecular
move
from
simplistic
framing
as
'leaky
gut'.
A
mechanistic
understanding
barriers,
especially
during
critical
windows
development,
be
aetiology
The
modulator
This
Review
provides
overview
examines
role
disease.
Frontiers in Neuroscience,
Год журнала:
2022,
Номер
16
Опубликована: Июнь 28, 2022
Neurological
diseases
are
difficult
to
diagnose
in
time,
and
there
is
currently
a
lack
of
effective
predictive
methods.
Previous
studies
have
indicated
that
variety
neurological
cause
changes
the
gut
microbiota.
Alpha
diversity
major
indicator
describe
At
present,
relationship
between
alpha
microbiota
remains
unclear.We
performed
systematic
literature
search
Pubmed
Bioproject
databases
up
January
2021.
Six
indices
were
used
measure
diversity,
including
community
richness
(observed
species,
Chao1
ACE),
(Shannon,
Simpson),
phylogenetic
(PD).
Random-effects
meta-analyses
on
standardized
mean
difference
(SMD)
carried
out
indices.
Subgroup
analyses
explore
sources
interstudy
heterogeneity.
Meta-analysis
was
articles
by
matching
age,
sex,
body
mass
index
(BMI)
disease
group
with
control
group.
Meanwhile,
subgroup
analysis
variability
sequencing
region,
platform,
geographical
instrument,
diseases.
The
area
under
curve
(AUC)
value
receiver
operating
characteristic
(ROC)
calculated
assess
prediction
effectiveness
microbial
indices.We
conducted
meta-analysis
24
published
16S
rRNA
gene
amplified
from
database
(patients,
n
=
1,469;
controls,
1,289).
pooled
estimate
demonstrated
no
significant
patients
controls
(P
<
0.05).
decreased
only
Parkinson's
patients,
while
it
increased
anorexia
nervosa
compared
controls.
After
adjusting
for
BMI,
none
associated
In
terms
Illumina
HiSeq
2000
V3-V5
results
showed
significantly
comparison
2500.
ROC
curves
suggested
could
be
as
biomarker
predict
AD
(Simpson,
AUC=
0.769,
P
0.0001),
MS
0.737,
0.001),
schizophrenia
(Chao1,
AUC
0.739,
0.002).Our
review
summarized
promising
predictor
AD,
schizophrenia,
MS,
but
not
all